Evidence map›Paper›PMID 36126206›Full record

ReviewDiabetes2022

Hypothesis: Induction of Autoimmunity in Type 1 Diabetes-A Lipid Focus.

Barbara E Corkey, Laurie E Kilpatrick, Carmella Evans-Molina

Open access · greenAbstract readReview
In one paragraph

Review in Diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. [Pathophysiologically complex bilateral profound sensorineural hearing loss in the setting of type 2 diabetes mellitus and fungal sepsis: a case report].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  2. Article
  3. Precision Medicine in Type 1 Diabetes.Journal of the Indian Institute of Science · 2023
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Barbara E CorkeyDepartment of Medicine, Boston University School of Medicine, Boston, MA.ORCID 0000-0002-5467-1630
Laurie E KilpatrickCenter for Inflammation and Lung Research, Department of Microbiology, Immunology and Inflammation, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
Carmella Evans-MolinaDepartments of Pediatrics and Medicine, Center for Diabetes and Metabolic Diseases, and the Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
Boston University · USRichard L. Roudebush VA Medical Center · USTemple University · US

Funding

Control of beta cell function and survival by RYR2-mediated calcium signalsR01DK127236 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2021 to 2025
$2.2M
BLRD VA I01 BX001733NIDDK NIH HHS R01 DK127236
6 · The paper itself

Abstract

Several unrelated findings led us to hypothesize that induction of autoimmunity is a consequence of a prior major inflammatory event in individuals with susceptible HLA phenotypes and elevated sensitivity to cytokines and free fatty acids (FFA). We observed provocative enhanced responsiveness of cultured human fibroblasts from individuals with type 1 diabetes (T1D), but not control subjects, to FFA and the inflammatory cytokines TNFα and IL1-β. Major infections increase inflammatory cytokines as well as circulating FFA. Endotoxin-treated animal models of sepsis also exhibit elevated inflammatory cytokines that inhibit FFA oxidation and elevate FFA. The pancreatic β-cell possesses low reactive oxygen species (ROS) scavenging capacity and responds to both elevated FFA and cytokines with increased ROS production, a combination that increases exocytosis and trafficking of secretory vesicles to the plasma membrane. Increased trafficking is accompanied by increased cycling of secretory granule proteins and may be linked with increased surface presentation of granule proteins to the immune system. We propose that this ultimately targets β-cell granular proteins at the cell surface and is consistent with the preponderance of autoantibodies to granule proteins. Our hypothesis encourages testing of potential early therapeutic interventions to prevent progression of β-cell destruction.

Indexed as

Diabetes Mellitus, Type 1AnimalsAutoantibodiesAutoimmunityCytokinesEndotoxinsFatty Acids, NonesterifiedHumansReactive Oxygen SpeciesTumor Necrosis Factor-alphaAutoantibodiesCytokinesEndotoxinsFatty Acids, NonesterifiedReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID36126206
PMCPMC10477405
OpenAlexW4296492060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.